AIP
ALTM

Ameritas Investment Partners’s Arcadium Lithium plc ALTM Stock Holding History

Ameritas Investment Partners’s Portfolio ALTM Stock Details ALTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-328,814
Closed -$1.69M – 3162
2024
Q4 		$1.69M Buy
328,814
+3,099
+1% +$15.8K 0.05% 408
2024
Q3 		$928K Hold
325,715
– – 0.03% 660
2024
Q2 		$1.09M Sell
325,715
-4,054
-1% -$16.9K 0.04% 590
2024
Q1 		$1.42M Buy
+329,769
New +$1.65M 0.05% 485

Other funds holding ALTM

VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
SFCL
Strengthening Families & Communities LLC Boston, Massachusetts $401M AUM 33.17% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.64B AUM 19.37% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

Ameritas Investment Partners's ALTM Position: Q1 2025 in Review

Ameritas Investment Partners sold out of Arcadium Lithium plc (ALTM) in Q1 2025, closing a stake of 328,814 shares — an estimated $1.69M sold.

Ameritas Investment Partners first reported a position in ALTM in Q1 2024 and held it in 4 quarters. The position peaked at $1.69M in Q4 2024. 6 funds tracked by Wall St. Rank hold ALTM as of Q1 2025.

  • Ameritas Investment Partners reported no remaining Arcadium Lithium plc position as of Q1 2025 after selling out during the quarter.
  • Ameritas Investment Partners sold 328,814 Arcadium Lithium plc shares in Q1 2025, an estimated $1.69M.
  • Ameritas Investment Partners first reported a position in Arcadium Lithium plc in Q1 2024 and held it in 4 quarters.
  • Ameritas Investment Partners's Arcadium Lithium plc position peaked at $1.69M in Q4 2024.
  • 6 funds tracked by Wall St. Rank held Arcadium Lithium plc as of Q1 2025.

Based on Ameritas Investment Partners's 13F filing for Q1 2025, filed 12 May 2025.